CMS announced it will award $10 million to the Navigator Program starting in the fall of 2018—representing a sharp decrease from $63 million in 2016.

Following attacks by President Trump on Twitter, drugmaker Pfizer backed down on its previously announced plan to raise drug prices on a number of prescriptions. Pfizer also announced Wednesday it will reorganize into three businesses, effective in 2019.

Retail giant Amazon is selling over-the-counter (OTC) medicines at lower prices than its brick-and-mortar competitors.

Brett Kavanaugh, President Donald Trump’s pick to replace Supreme Court Justice Anthony Kennedy and a D.C. Appeals Court judge, will likely face questions on his healthcare record during confirmation hearings.

CMS has announced participants in the Bundled Payment for Care Improvement (BPCI) Advanced model will be able to retroactively withdraw beginning in March 2019.

President Donald Trump lashed out at drug manufacturer Pfizer after the company raised prices for 100 drugs by an average of 9 percent, effective July 1.

States are desperate to act in the national opioid epidemic, but laws limiting opioid prescriptions and doses are negatively impacting chronic pain patients and leaving doctors conflicted about care delivery, NPR reported.

On July 7, CMS announced it will stop making risk adjustment payments, which were designed as part of the Affordable Care Act (ACA) to help insurers that accept more high-cost patients avoid major losses.